Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barin

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Virus Research|July 7, 1999
HIV-1 subtype B in HondurasB Renjifo, J T Blackard, W Klaskala, et al.
The Journal of Infectious Diseases|December 8, 1998
Human immunodeficiency virus type 1 subtypes differ in disease progressionP J Kanki, D J Hamel, J L Sankalé, et al.
Journal of Virology|September 19, 2014
Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodiesM Bouvin-Pley, M Morgand, L Meyer, et al.
Ebiomedicine|December 24, 2017
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSMM Bendenoun, A Samri, V Avettand-Fènoël, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide studyL Assoumou, C Charpentier, P Recordon-Pinson, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Virus Research|July 7, 1999
HIV-1 subtype B in HondurasB Renjifo, J T Blackard, W Klaskala, et al.
The Journal of Infectious Diseases|December 8, 1998
Human immunodeficiency virus type 1 subtypes differ in disease progressionP J Kanki, D J Hamel, J L Sankalé, et al.
Journal of Virology|September 19, 2014
Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodiesM Bouvin-Pley, M Morgand, L Meyer, et al.
Ebiomedicine|December 24, 2017
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSMM Bendenoun, A Samri, V Avettand-Fènoël, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide studyL Assoumou, C Charpentier, P Recordon-Pinson, et al.
Pageof 18